Release of Retinal Extracellular Vesicles in a Model of Retinitis Pigmentosa.


Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2019
Historique:
entrez: 30 12 2019
pubmed: 31 12 2019
medline: 6 2 2020
Statut: ppublish

Résumé

Extracellular vesicles (EVs) are membranous structures released by cells, including those of the retinal pigment epithelium (RPE) and photoreceptors. The cargo of EVs includes genetic material and proteins, making these vesicles essential in cell communication. Among the genetic materials, we find a large number of microRNAs (miRNAs), small chains of noncoding RNA. In the case of EVs from the retina, changes have also been observed in the number and cargo of EVs.Our group confirmed that damaged RPE cells in vitro release a greater number of EVs with a higher pro-angiogenic factor (VEGFR-1 and VEGFR-2) than control non-damaged cells, thus increasing neovascularization in endothelial cell cultures. This indicates that something similar could happen in patients suffering from some types of retinal degeneration that occur with angiogenesis, such as wet AMD or RD.Here, we investigated the role of EVs in photoreceptor degeneration, and we report for the first time on CD9 and CD81, closely related tetraspanins, in wild-type and rd1 retinae. Our study demonstrates the involvement of EVs in the process of inherited photoreceptor degeneration in a PDE6 mutation.

Identifiants

pubmed: 31884650
doi: 10.1007/978-3-030-27378-1_71
doi:

Substances chimiques

Tetraspanin 28 0
Tetraspanin 29 0
KDR protein, human EC 2.7.10.1
Vascular Endothelial Growth Factor Receptor-1 EC 2.7.10.1
Vascular Endothelial Growth Factor Receptor-2 EC 2.7.10.1
Cyclic Nucleotide Phosphodiesterases, Type 6 EC 3.1.4.35

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

431-436

Auteurs

Ayse Sahaboglu (A)

Division of Experimental Ophthalmology, Institute for Ophthalmic Research, Tübingen, Germany.

Lorena Vidal-Gil (L)

Escuela de doctorado, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain. lorena.vidal@ucv.es.
Neurobiología y Neurofisiología, Facultad de Medicina y Odontología, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain. lorena.vidal@ucv.es.

Javier Sancho-Pelluz (J)

Neurobiología y Neurofisiología, Facultad de Medicina y Odontología, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH